{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:52:54Z","timestamp":1790031174120,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"China National Key Technologies R&D Program for the 13th Five-year Plan","award":["2017ZX10202101-001"],"award-info":[{"award-number":["2017ZX10202101-001"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["CAMS-I2M-1-014"],"award-info":[{"award-number":["CAMS-I2M-1-014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2866-y","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T13:50:34Z","timestamp":1513345834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A higher CD4\/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study"],"prefix":"10.1186","volume":"17","author":[{"given":"Yongsong","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Routy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"issue":"8","key":"2866_CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","volume":"12","author":"SG Deeks","year":"2012","unstructured":"Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12(8):607\u201314.","journal-title":"Nat Rev Immunol"},{"issue":"17","key":"2866_CR2","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1128\/JVI.01046-14","volume":"88","author":"MJ Buzon","year":"2014","unstructured":"Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, et al. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol. 2014;88(17):10056\u201365.","journal-title":"J Virol"},{"issue":"5341","key":"2866_CR3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","volume":"278","author":"JK Wong","year":"1997","unstructured":"Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278(5341):1291\u20135.","journal-title":"Science"},{"issue":"5341","key":"2866_CR4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295\u2013300.","journal-title":"Science"},{"issue":"24","key":"2866_CR5","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","volume":"94","author":"TW Chun","year":"1997","unstructured":"Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997;94(24):13193\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2866_CR6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tim.2016.01.006","volume":"24","author":"K Barton","year":"2016","unstructured":"Barton K, Winckelmann A, Palmer S. HIV-1 reservoirs during suppressive therapy. Trends Microbiol. 2016;24(5):345\u201355.","journal-title":"Trends Microbiol"},{"key":"2866_CR7","volume":"3","author":"JP Williams","year":"2014","unstructured":"Williams JP, Hurst J, Stohr W, Robinson N, Brown H, Fisher M, et al. HIV-1 DNA predicts disease progression and post-treatment virological control. elife. 2014;3:e03821.","journal-title":"elife"},{"issue":"3","key":"2866_CR8","first-page":"343","volume":"30","author":"JZ Li","year":"2016","unstructured":"Li JZ, Etemad B, Ahmed H, Aga E, Bosch RJ, Mellors JW, et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS. 2016;30(3):343\u201353.","journal-title":"AIDS"},{"issue":"1","key":"2866_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/430610","volume":"192","author":"C Rouzioux","year":"2005","unstructured":"Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, Bary M, et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis. 2005;192(1):46\u201355.","journal-title":"J Infect Dis"},{"key":"2866_CR10","doi-asserted-by":"crossref","unstructured":"Gianotti N, Canducci F, Galli L, Cossarini F, Salpietro S, Poli A, et al. HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients. Clin Microbiol Infect. 2015;21(1):103 e7- e10.","DOI":"10.1016\/j.cmi.2014.08.004"},{"issue":"16","key":"2866_CR11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32833032d4","volume":"23","author":"M Burgard","year":"2009","unstructured":"Burgard M, Boufassa F, Viard JP, Garrigue I, Ruffault A, Izopet J, et al. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients. AIDS. 2009;23(16):2165\u201371.","journal-title":"AIDS"},{"issue":"1","key":"2866_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcv.2011.09.018","volume":"53","author":"MR Boulassel","year":"2012","unstructured":"Boulassel MR, Chomont N, Pai NP, Gilmore N, Sekaly RP, Routy JP. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2012;53(1):29\u201332.","journal-title":"J Clin Virol"},{"key":"2866_CR13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2334-11-146","volume":"11","author":"D Watanabe","year":"2011","unstructured":"Watanabe D, Ibe S, Uehira T, Minami R, Sasakawa A, Yajima K, et al. Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration. BMC Infect Dis. 2011;11:146.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"2866_CR14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jac\/dks533","volume":"68","author":"L Hocqueloux","year":"2013","unstructured":"Hocqueloux L, Avettand-Fenoel V, Jacquot S, Prazuck T, Legac E, Melard A, et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J Antimicrob Chemother. 2013;68(5):1169\u201378.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2866_CR15","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1128\/JCM.43.12.6183-6185.2005","volume":"43","author":"L Sarmati","year":"2005","unstructured":"Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Palmisano L, Andreotti M, et al. Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy. J Clin Microbiol. 2005;43(12):6183\u20135.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2866_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/jis630","volume":"208","author":"H Hatano","year":"2013","unstructured":"Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, et al. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis. 2013;208(1):50\u20136.","journal-title":"J Infect Dis"},{"issue":"9","key":"2866_CR17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ebiom.2015.07.025","volume":"2","author":"A Ruggiero","year":"2015","unstructured":"Ruggiero A, De Spiegelaere W, Cozzi-Lepri A, Kiselinova M, Pollakis G, Beloukas A, et al. During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR\/DP\/DQ. EBioMedicine. 2015;2(9):1153\u20139.","journal-title":"EBioMedicine"},{"issue":"19","key":"2866_CR18","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","volume":"369","author":"D Persaud","year":"2013","unstructured":"Persaud D, Gay H, Ziemniak C, Chen YH, Piatak M Jr, Chun TW, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med. 2013;369(19):1828\u201335.","journal-title":"N Engl J Med"},{"issue":"3","key":"2866_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003211","volume":"9","author":"A Saez-Cirion","year":"2013","unstructured":"Saez-Cirion A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLoS Pathog. 2013;9(3):e1003211.","journal-title":"PLoS Pathog"},{"issue":"1","key":"2866_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3760\/cma.j.issn.0366-6999.20132557","volume":"127","author":"T Li","year":"2014","unstructured":"Li T, Guo F, Li Y, Zhang C, Han Y, Lye W, et al. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China. Chin Med J. 2014;127(1):59\u201365.","journal-title":"Chin Med J"},{"issue":"1","key":"2866_CR21","volume":"19","author":"J Xie","year":"2016","unstructured":"Xie J, Han Y, Qiu Z, Li Y, Li Y, Song X, et al. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study. J Int AIDS Soc. 2016;19(1):20659.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"2866_CR22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2016.08.018","volume":"45","author":"EK Cartwright","year":"2016","unstructured":"Cartwright EK, Spicer L, Smith SA, Lee D, Fast R, Paganini S, et al. CD8(+) lymphocytes are required for maintaining viral suppression in SIV-infected macaques treated with short-term antiretroviral therapy. Immunity. 2016;45(3):656\u201368.","journal-title":"Immunity"},{"key":"2866_CR23","doi-asserted-by":"crossref","unstructured":"Cao W, Mehraj V, Kaufmann DE, Li T, Routy J-P. Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era. J Int AIDS Soc. 2016;19(1)","DOI":"10.7448\/IAS.19.1.20697"},{"issue":"11","key":"2866_CR24","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1086\/340521","volume":"185","author":"TW Chun","year":"2002","unstructured":"Chun TW, Justement JS, Pandya P, Hallahan CW, McLaughlin M, Liu S, et al. Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis. 2002;185(11):1672\u20136.","journal-title":"J Infect Dis"},{"issue":"4","key":"2866_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006285","volume":"13","author":"RT Gandhi","year":"2017","unstructured":"Gandhi RT, McMahon DK, Bosch RJ, Lalama CM, Cyktor JC, Macatangay BJ, et al. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. PLoS Pathog. 2017;13(4):e1006285.","journal-title":"PLoS Pathog"},{"issue":"2","key":"2866_CR26","first-page":"114","volume":"2","author":"JM Taylor","year":"1989","unstructured":"Taylor JM, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr. 1989;2(2):114\u201324.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2866_CR27","first-page":"57","volume":"66","author":"S Serrano-Villar","year":"2013","unstructured":"Serrano-Villar S, Gutierrez C, Vallejo A, Hernandez-Novoa B, Diaz L, Abad Fernandez M, et al. The CD4\/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Inf Secur. 2013;66(1):57\u201366.","journal-title":"J Inf Secur"},{"issue":"1","key":"2866_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085798","volume":"9","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Perez-Elias MJ, Dronda F, Casado JL, Moreno A, Royuela A, et al. Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4\/CD8 ratio. PLoS One. 2014;9(1):e85798.","journal-title":"PLoS One"},{"issue":"5","key":"2866_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, et al. HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014;10(5):e1004078.","journal-title":"PLoS Pathog"},{"issue":"5","key":"2866_CR30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/COH.0000000000000086","volume":"9","author":"JC Mudd","year":"2014","unstructured":"Mudd JC, Lederman MM. CD8 T cell persistence in treated HIV infection. Curr Opin HIV AIDS. 2014;9(5):500\u20135.","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"2866_CR31","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","volume":"2","author":"C Mussini","year":"2015","unstructured":"Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E, et al. CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV. 2015;2(3):e98\u2013106.","journal-title":"Lancet HIV"},{"issue":"10","key":"2866_CR32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110731","volume":"9","author":"LR Cockerham","year":"2014","unstructured":"Cockerham LR, Siliciano JD, Sinclair E, O'Doherty U, Palmer S, Yukl SA, et al. CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells. PLoS One. 2014;9(10):e110731.","journal-title":"PLoS One"},{"issue":"6","key":"2866_CR33","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/JVI.03331-13","volume":"88","author":"JM Murray","year":"2014","unstructured":"Murray JM, Zaunders JJ, McBride KL, Xu Y, Bailey M, Suzuki K, et al. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy. J Virol. 2014;88(6):3516\u201326.","journal-title":"J Virol"},{"issue":"8","key":"2866_CR34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15(8):893\u2013900.","journal-title":"Nat Med"},{"issue":"6193","key":"2866_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1255512","volume":"345","author":"DH Barouch","year":"2014","unstructured":"Barouch DH, Deeks SG. Immunologic strategies for HIV-1 remission and eradication. Science. 2014;345(6193):169\u201374.","journal-title":"Science"},{"issue":"6","key":"2866_CR36","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/JVI.02356-09","volume":"84","author":"TW North","year":"2010","unstructured":"North TW, Higgins J, Deere JD, Hayes TL, Villalobos A, Adamson L, et al. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol. 2010;84(6):2913\u201322.","journal-title":"J Virol"},{"issue":"2","key":"2866_CR37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11904-014-0207-y","volume":"11","author":"V Svicher","year":"2014","unstructured":"Svicher V, Ceccherini-Silberstein F, Antinori A, Aquaro S, Perno CF, Understanding HIV. Compartments and reservoirs. Curr HIV\/AIDS Rep. 2014;11(2):186\u201394.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"2866_CR38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/QAD.0000000000000987","volume":"30","author":"R Calin","year":"2016","unstructured":"Calin R, Hamimi C, Lambert-Niclot S, Carcelain G, Bellet J, Assoumou L, et al. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir. AIDS. 2016;30(5):761\u20139.","journal-title":"AIDS"},{"issue":"2","key":"2866_CR39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1179\/1528433614Z.0000000005","volume":"16","author":"T Li","year":"2015","unstructured":"Li T, Xie J, Li Y, Routy JP, Li Y, Han Y, et al. Tripterygium wilfordii hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety. HIV Clin Trials. 2015;16(2):49\u201356.","journal-title":"HIV Clin Trials"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T19:24:10Z","timestamp":1719689050000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2866-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2866"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2866-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"771"}}